Speakers:

• Anand Anandkumar, Co-founder and CEO Bugworks Research Inc (India)
• Kamini Walia, Program Officer, ICMR-AMR Initiative (India) 

Moderator: François Franceschi, GARDP 

In this webinar, Anand Anandkumar and Kamini Walia will discuss:

• Why is India one of the hotbeds of the AMR problem? Latest statistics of growing drug resistance etc.
• Initiatives of the Indian Government to curb the AMR problem
• Antimicrobial R&D landscape in India – a vibrant ecosystem supporting innovation in AMR diagnosis, prevention and therapeutics
• Fledgling antimicrobial clinical trial networks – could trials out of India play a significant role in gaining global regulatory approvals?
• Changing regulatory environment to enable accelerated approvals for antimicrobial products

The presentation will be followed by a Q&A session.

Register now for this live webinar including interactive Q&A session on 5 May 2020, 9:00-10:30 am CEST (find your time zone here).